Article info

Download PDFPDF
BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma
  1. Correspondence to Dr P D Alexandar Tzankov, University Hospital Basel, Institute of Pathology, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland; atzankov{at}uhbs.ch
View Full Text

Citation

Obermann EC, Csato M, Dirnhofer S, et al
BCL2 gene aberration as an IPI-independent marker for poor outcome in non-germinal-centre diffuse large B cell lymphoma

Publication history

  • Accepted June 18, 2009
  • First published September 25, 2009.
Online issue publication 
September 25, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.